Background: The analysis of cellular networks and pathways involved in oncogenesis has increased our knowledge about the pathogenic mechanisms that underlie tumour biology and has unmasked new molecular targets that may lead to the design of better anti-cancer therapies. Recently, using a high resolution loss of heterozygosity (LOH) analysis, we identified a number of potential tumour suppressor genes (TSGs) within common LOH regions across cases suffering from two of the most common forms of Non-Hodgkin's lymphoma (NHL), Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL). From these studies LOH of the protein tyrosine phosphatase receptor type J (PTPRJ) gene was identified as a common event in the lymphomagenesis of these B...
BACKGROUND: The pathogenesis of several subtypes of non-Hodgkin's lymphoma (NHL) is associated with ...
PhDFollicular lymphoma (FL) is an incurable indolent non-Hodgkin’s lymphoma (NHL) that behaves heter...
Recent developments in genomic technologies have resulted in increased understanding of pathogenic m...
Background The analysis of cellular networks and pathways involved in oncogenesis has increased our ...
Background\ud \ud The analysis of cellular networks and pathways involved in oncogenesis has increas...
Free to read We employed a Hidden-Markov-Model (HMM) algorithm in loss of heterozygosity (LOH) analy...
Free to read\ud \ud We employed a Hidden-Markov-Model (HMM) algorithm in loss of heterozygosity (LOH...
silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in t...
Lymphomas represent the outgrowth of a clonal population of T- or B- lymphocytes. The majority of hu...
We recently reported deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphob...
Next generation sequencing (NGS) technology has led to a burst of disease-relevant molecular informa...
Next generation sequencing (NGS) technology has led to a burst of disease-relevant molecular informa...
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In certain tumo...
Non-Hodgkin lymphoma (NHL) is the 13th most common type of cancer worldwide in 2020 and consists mai...
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma and frequently...
BACKGROUND: The pathogenesis of several subtypes of non-Hodgkin's lymphoma (NHL) is associated with ...
PhDFollicular lymphoma (FL) is an incurable indolent non-Hodgkin’s lymphoma (NHL) that behaves heter...
Recent developments in genomic technologies have resulted in increased understanding of pathogenic m...
Background The analysis of cellular networks and pathways involved in oncogenesis has increased our ...
Background\ud \ud The analysis of cellular networks and pathways involved in oncogenesis has increas...
Free to read We employed a Hidden-Markov-Model (HMM) algorithm in loss of heterozygosity (LOH) analy...
Free to read\ud \ud We employed a Hidden-Markov-Model (HMM) algorithm in loss of heterozygosity (LOH...
silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in t...
Lymphomas represent the outgrowth of a clonal population of T- or B- lymphocytes. The majority of hu...
We recently reported deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphob...
Next generation sequencing (NGS) technology has led to a burst of disease-relevant molecular informa...
Next generation sequencing (NGS) technology has led to a burst of disease-relevant molecular informa...
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In certain tumo...
Non-Hodgkin lymphoma (NHL) is the 13th most common type of cancer worldwide in 2020 and consists mai...
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma and frequently...
BACKGROUND: The pathogenesis of several subtypes of non-Hodgkin's lymphoma (NHL) is associated with ...
PhDFollicular lymphoma (FL) is an incurable indolent non-Hodgkin’s lymphoma (NHL) that behaves heter...
Recent developments in genomic technologies have resulted in increased understanding of pathogenic m...